Form 4: XOMA Royalty Corp Director Joseph Limber Granted 9,936 Stock Options

XOMA Royalty Corp's Director, Joseph M. Limber, was granted 9,936 non-qualified stock options with an exercise price of $25.12, vesting over 12 months.

Summary

• Joseph M. Limber, a Director of XOMA Royalty Corp (XOMA), was granted 9,936 non-qualified share options.
• The options have an exercise price of $25.12 per share.
• The transaction date for the option grant was May 21, 2025.
• The options will vest in equal monthly installments over a 12-month period following the grant date (May 21, 2025).
• The final installment of vesting will occur on the earlier of the next annual meeting of the Company's stockholders or the first anniversary of the grant date.
• Vesting is contingent upon Mr. Limber's continued service to the Company through each vesting date.
• The options have an expiration date of May 21, 2035.
• Following this transaction, Joseph M. Limber beneficially owns 9,936 derivative securities (options).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the option grant aligns the director's interests with shareholders and is a standard compensation practice, indicating stability in governance. There are no negative operational or financial implications directly from this filing.

Positives

• The grant of stock options to a director, Joseph M. Limber, aligns his interests with those of the shareholders, incentivizing long-term performance and value creation.
• Equity compensation is a common practice to attract and retain experienced board members.

Negatives

• The exercise of these options in the future could lead to a slight dilution of existing shareholders' equity, although the amount is relatively small.

Risks

• The value of the options is dependent on the future market price of XOMA Royalty Corp's common shares; if the share price does not exceed the exercise price of $25.12, the options may not be in-the-money.
• The vesting of options is subject to the director's continued service, meaning the full benefit is not immediate and could be forfeited if service ceases prematurely.

Future Outlook

The options granted to Director Joseph M. Limber are set to vest in equal monthly installments over the 12-month period following the May 21, 2025 grant date, subject to his continued service to the company. This provides a future incentive tied to the company's performance.

Industry Context

The granting of stock options to directors is a standard practice across various industries, including the biotechnology and royalty sectors, as a form of long-term incentive compensation. It aims to align the interests of the board members with the long-term performance and shareholder value of the company.

Comparison to Industry Standards

• The grant of stock options to directors is a common component of executive and board compensation packages across publicly traded companies, including those in the biotech and royalty sectors.
• The vesting schedule of 12 months is relatively short compared to some multi-year vesting schedules, but it is not uncommon for director grants which often vest over a single year or until the next annual meeting.
• The exercise price being at or above the market price on the grant date (implied by 'Non-Qualified Share Option' and typical grant practices) is standard for incentive options.

Corporate Governance

Related Party Transactions

• The grant of stock options to Joseph M. Limber, a director of XOMA Royalty Corp, constitutes a related party transaction as it involves compensation provided to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: Potential for slight future dilution if options are exercised, but also benefit from increased alignment of director's interests with long-term company performance.
• Employees (specifically Joseph M. Limber): Receives equity compensation, providing a direct financial incentive tied to the company's stock performance and continued service.

Next Steps

• The options granted to Joseph M. Limber will begin vesting in equal monthly installments over the 12-month period following May 21, 2025.
• The final vesting installment will occur on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date.

Key Dates

Keywords

XOMA Royalty Corp, XOMA, Form 4, insider transaction, stock options, equity compensation, director compensation, beneficial ownership, non-qualified options